Vaccine and Treatment
For information about the COVID-19 vaccine and treatment, please use the drop-downs below:
(+ opens section, - closes section)
As of 4/12/2021
- As of April 12, the RI Department of Health will start vaccinating people 40+ years of age as well as 16 - 64 with underlying health conditions (view a list of underlying medical conditions). Towns are also giving the vacines. Click here for COVID-19 Vaccination Information in Your Community
- You can make an appointment at state vaccination centers and town vaccination sites posted on the RI Department of Health website, www.vaccinateri.org.
- You can also sign up on the websites of retail pharmacies at www.cvs.com and www.walgreens.com.
- To receive updates as eligibility opens to new groups, click on the following link: Join the RIDOH’s Vaccine Interest Notification List. Enrolling in this list does NOT guarantee an appointment for vaccination.
- Coastal patients may have the opportunity to receive the vaccine at locations other than Coastal Medical offices. If you are eligible for the vaccine through a non-Coastal location, we encourage you receive it through one of those other community resources.
Coastal is committed to keeping you informed with the most current news regarding the COVID-19 vaccine availability in Rhode Island and at Coastal Medical. Rest assured that we will share those updates with you as soon as we get them.
Please see below for an update on the COVID-19 vaccine from Coastal Medical's Chief Medical Officer, Dr. Ed McGookin:
Frequently asked questions about the COVID-19 Vaccine
COVID-19 Vaccine FAQ Sheet
What You Need To Know About COVID-19 Vaccine
Is the COVID-19 Vaccine Safe?
How mRNA Vaccines Work
What Happens After Your COVID-19 Vaccination?
When You've Been Fully Vaccinated - How to Protect Yourself and Others
What Underlying Medical Conditions are Eligible for COVID-19 Vaccinations (age 16 and above)?
Underlying Medical Conditions
- Patient information on Bamlanivimab
Patient information on Regeneron (Casirivimab and Imdevimab)
- Frequently asked questions on the emergency use authorization of Regeneron (Casirivimab and Imdevimab)